Skip to main content
. 2022 Feb 25;14(5):1214. doi: 10.3390/cancers14051214

Table 3.

The results of QoL assessment (EORTC QLQ-C30 functional scales) in patient groups differing with respect to the level of illness acceptance; and the results of the analysis of variance.

QoL Assessed with EORTC QLQ-C30 Level of Illness Acceptance (AIS) ANOVA
p
High
Acceptance
30–40 pts.		 Moderate
Acceptance
19–29 pts.		 Low
Acceptance
8–18 pts.
n = 101 n = 69 n = 32
Global health status/QoL (QL) 0.001
M ± SD 64.7 ± 16.3 57.7 ± 18.6 37.8 ± 24.4
Me (Q1; Q3) 67 [50; 75] 58 [50; 67] 33 [17; 58]
Min–Max 17–100 8–100 0–83
Physical functioning (PF) 0.001
M ± SD 40.4 ± 24.4 22.5 ± 13.9 19.9 ± 13.7
Me (Q1; Q3) 43 [18; 60] 20 [13; 27] 20 [7; 27]
Min–Max 7–87 0–73 0–60
Role functioning (RF) 0.001
M ± SD 39.1 ± 28.3 18.1 ± 18.9 15.0 ± 17.1
Me (Q1; Q3) 33 [17; 67] 17 [0; 17] 17 [0; 17]
Min–Max 0–100 0–67 0–67
Emotional functioning (EF) 0.001
M ± SD 53.1 ± 25.3 41.5 ± 26.0 30.1 ± 19.9
Me (Q1; Q3) 58 [33; 75] 33 [17; 67] 25 [17; 33]
Min–Max 0–92 0–100 0–92
Cognitive functioning (CF) 0.001
M ± SD 43.2 ± 32.5 25.1 ± 23.5 18.6 ± 20.3
Me (Q1; Q3) 33 [17; 67] 17 [0; 33] 17 [0; 33]
Min–Max 0–100 0–100 0–83
Social functioning (SF) 0.001
M ± SD 47.4 ± 29.1 31.2 ± 22.7 22.3 ± 20.2
Me (Q1; Q3) 50 [29; 67] 33 [17; 50] 17 [0; 33]
Min–Max 0–100 0–100 0–100

M—mean; SD—standard deviation; Me—median; Q1—lower quartile; Q3—upper quartile; Min—lowest value; Max—highest value; n—number; values in bold indicate statistical significance (p < 0.05).